Indeed, the log‐rank test demonstrated that the overall survival for patients with low TPD52 expression in tumor tissues was significantly higher than those with high TPD52 expression (p = 0.0036, Figure 5A), suggesting that TPD52 expression correlates with poor patient prognosis. The gene discussed is TPD52; the disease is neoplasm.